ometendoОжирение и метаболизмObesity and metabolism2071-87132306-5524Endocrinology Research Centre10.14341/omet12983ometendo-12983Research ArticleКЛИНИЧЕСКИЕ СЛУЧАИCASE REPORTSБариатрический пациент: в чем залог успеха? Случай из практикиBariatric patient: what is the key to success? Case from practicehttps://orcid.org/0000-0002-6220-4397ЕршоваЕ. В.ErshovaE. V.

Ершова Екатерина Владимировна, к.м.н.

117036, Москва, ул. Дм. Ульянова, д. 11

Ekaterina V. Ershova, MD, PhD

11 Dm.Ulyanova street, 117036 Moscow

Ershova.Ekaterina@endocrincentr.ruhttps://orcid.org/0009-0001-6204-4231ФролковаН. В.FrolkovaN. V.

Фролкова Надежда Викторовна 

Москва

Nadezhda V. Frolkova, MD

Moscow

nadya.frolkova@mail.ruhttps://orcid.org/0000-0002-6624-2374КомшиловаК. А.KomshilovaK. A.

Комшилова Ксения Андреевна, к.м.н. 

Москва

Kseniya A. Komshilova, MD, PhD

Moscow

 

Komshilova.Kseniya@endocrincentr.ruhttps://orcid.org/0000-0001-8077-9381МазуринаН. В.MazurinaN. V.

Мазурина Наталия Валентиновна, д.м.н. 

Москва

Natalya V. Mazurina, MD, PhD

Moscow

 

Mazurina.Natalya@endocrincentr.ruНациональный медицинский исследовательский центр эндокринологииРоссияEndocrinology Research CentreRussian Federation202306062023202163169Copyright © Ершова Е.В., Фролкова Н.В., Комшилова К.А., Мазурина Н.В., 20232023Ершова Е.В., Фролкова Н.В., Комшилова К.А., Мазурина Н.В.Ershova E.V., Frolkova N.V., Komshilova K.A., Mazurina N.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.omet-endojournals.ru/jour/article/view/12983

Хирургическое лечение в объеме лапароскопического гастрошунтирования по поводу морбидного ожирения и сахарного диабета 2 типа (СД2) с тщательной предоперационной подготовкой, поэтапным расширением пищевого рациона с обязательным соблюдением рекомендаций диетолога по балансу микро- и макронутриентов, постепенным увеличением объема доступной физической активности в послеоперационном периоде позволяет не только значительно снизить массу тела, но и добиться компенсации сопутствующих ожирению заболеваний. Ожидаемое развитие дефицита микро- и макронутриентов требует активного поиска и компенсации этих состояний как на до-, так и на послеоперационном этапе. Развитие постбариатрических гипогликемий подтверждает необходимость соблюдения диетических рекомендаций не только на этапе консервативного лечения ожирения и СД2, но и, что не менее важно, после бариатрической операции.

Surgical treatment in the scope of laparoscopic gastric bypass for morbid obesity and type 2 diabetes mellitus (DM 2) with careful preoperative preparation, a gradual expansion of the diet with the obligatory observance of the recommendations of a nutritionist on the balance of micro- and macronutrients, a gradual increase in the amount of available physical activity in the postoperative period allows not only significantly reduce body weight, but also achieve compensation for obesity-related diseases. The expected development of micro- and macronutrient deficiencies requires an active search for and compensation for these conditions both at the pre- and postoperative stages. The development of postbariatric hypoglycemia confirms the need to comply with dietary recommendations not only at the stage of conservative treatment of obesity and DM 2, but also, no less important, after bariatric surgery.

Ожирениесахарный диабет 2 типабариатрические операцииметаболическая хирургиягастрошунтированиемальабсорбципостбариатрические гипогликемии.obesitytype 2 diabetes mellitusbariatric surgerymetabolic surgerygastric bypassmalabsorptionpostbariatric hypoglycemiaРабота проведена в рамках выполнения Государственного задания Минздрава России (Рег. N НИОКТР 122012100180-0).ReferencesBuchwald H., Varco R. Metabolic Surgery. New York: Grune & Stratton. – 1978. – Сhap. 11Buchwald H., Varco R. Metabolic Surgery. New York: Grune & Stratton. – 1978. – Сhap. 11Kremen A, Linner J, Nelson C. An experimental evaluation of the nutritional importance of proximal and distal small intestine. Ann Surg. 1954; 140:439–444 DOI: 10.1097/00000658-195409000-00018Kremen A, Linner J, Nelson C. An experimental evaluation of the nutritional importance of proximal and distal small intestine. Ann Surg. 1954; 140:439–444 DOI: 10.1097/00000658-195409000-00018Payne J, DeWind L, Commons R. Metabolic observations in patients with jejunocolic shunts. Am J Surg. 1963; 106:273–289 DOI: 10.1016/0002-9610(63)90017-5Payne J, DeWind L, Commons R. Metabolic observations in patients with jejunocolic shunts. Am J Surg. 1963; 106:273–289 DOI: 10.1016/0002-9610(63)90017-5Mason E., Ito C. Gastric bypass in obesity. Surg Clinics North Am. 1967; 47(6):1345–51. DOI: 10.1016/s0039-6109(16)38384-0Mason E., Ito C. Gastric bypass in obesity. Surg Clinics North Am. 1967; 47(6):1345–51. DOI: 10.1016/s0039-6109(16)38384-0Pories W., MacDonald K., Flickinger E. et al. Is type II diabetes mellitus (NIDDM) a surgical disease? Ann Surg. 1992; 215:633–42 DOI: 10.1097/00000658-199206000-00010Pories W., MacDonald K., Flickinger E. et al. Is type II diabetes mellitus (NIDDM) a surgical disease? Ann Surg. 1992; 215:633–42 DOI: 10.1097/00000658-199206000-00010Pories W., Swanson M., MacDonald K. et al. Who would have thought it? An operation proves to be the most effective therapy for adult onset diabetes mellitus. Ann Surg. 1995; 222:339–52 DOI: 10.1097/00000658-199509000-00011Pories W., Swanson M., MacDonald K. et al. Who would have thought it? An operation proves to be the most effective therapy for adult onset diabetes mellitus. Ann Surg. 1995; 222:339–52 DOI: 10.1097/00000658-199509000-00011Laferrere B., Heshka S., Wang K. et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care. 2007; 30:1709–16 DOI: 10.2337/dc06-1549Laferrere B., Heshka S., Wang K. et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care. 2007; 30:1709–16 DOI: 10.2337/dc06-1549Ершова Е.В. Обмен глюкозы, липидов и продукция инкретинов у пациентов с ожирением и сахарным диабетом 2 типа после билиопанкреатического шунтирования: дис. … канд. мед. наук: 14.01.02 / Ершова Е.В. – М., 2016 - 137 сErshova EV. Obmen gljukozy, lipidov i produkcija inkretinov u pacientov s ozhireniem i saharnym diabetom 2 tipa posle biliopankreaticheskogo shuntirovanija [dissertation]. Moscow; 2016. (In Russ.)].Buchwald H., Avidor Y., Braunwald E. et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004; 292: 1724-37 DOI: 10.1001/jama.292.14.1724Buchwald H., Avidor Y., Braunwald E. et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004; 292: 1724-37 DOI: 10.1001/jama.292.14.1724Buchwald H., Estok R., Fahrbach K. et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007; 142: 621-32 DOI: 10.1016/j.surg.2007.07.018Buchwald H., Estok R., Fahrbach K. et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007; 142: 621-32 DOI: 10.1016/j.surg.2007.07.018Buchwald H., Estok R., Fahrbach K. et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009; 122: 249-61 DOI: 10.1016/j.amjmed.2008.09.041Buchwald H., Estok R., Fahrbach K. et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009; 122: 249-61 DOI: 10.1016/j.amjmed.2008.09.041Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012; 366(17):1577–85 DOI: 10.1056/NEJMoa1200111Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012; 366(17):1577–85 DOI: 10.1056/NEJMoa1200111Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med. 2017; 376(7):641–651 DOI: 10.1056/NEJMoa1600869Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med. 2017; 376(7):641–651 DOI: 10.1056/NEJMoa1600869Khorgami Z, Shoar S, Saber AA, et al. Outcomes of bariatric surgery versus medical management for type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Obes Surg. 2019; 29(3):964–974 DOI: 10.1007/s11695-018-3552-xKhorgami Z, Shoar S, Saber AA, et al. Outcomes of bariatric surgery versus medical management for type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Obes Surg. 2019; 29(3):964–974 DOI: 10.1007/s11695-018-3552-xAminian A. Bariatric procedure selection in patients with type 2 diabetes: choice between Roux-en-Y gastric bypass or sleeve gastrectomy. Surg Obes Relat Dis. 2020; 16(2):332–339 DOI: 10.1016/j.soard.2019.11.013Aminian A. Bariatric procedure selection in patients with type 2 diabetes: choice between Roux-en-Y gastric bypass or sleeve gastrectomy. Surg Obes Relat Dis. 2020; 16(2):332–339 DOI: 10.1016/j.soard.2019.11.013Ikramuddin S, Korner J, Lee W-J, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the diabetes surgery study randomized clinical trial. JAMA. 2013; 309:2240–49 DOI: 10.1001/jama.2013.5835Ikramuddin S, Korner J, Lee W-J, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the diabetes surgery study randomized clinical trial. JAMA. 2013; 309:2240–49 DOI: 10.1001/jama.2013.5835Ikramuddin S, Korner J, Lee W-J, et al. Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study. JAMA. 2018; 319(3):266-278. doi: 10.1001/jama.2017.20813 DOI: 10.1001/jama.2017.20813Ikramuddin S, Korner J, Lee W-J, et al. Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study. JAMA. 2018; 319(3):266-278. doi: 10.1001/jama.2017.20813 DOI: 10.1001/jama.2017.20813Mechanick J., Apovian С., Brethauer S. еt al. Clinical Practice Guidelines For The Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures – 2019 Update. Endocr Pract. 2019; 25(12):1346-59. doi: 10.4158/GL-2019-0406 DOI: 10.1002/oby.22719Mechanick J., Apovian С., Brethauer S. еt al. Clinical Practice Guidelines For The Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures – 2019 Update. Endocr Pract. 2019; 25(12):1346-59. doi: 10.4158/GL-2019-0406 DOI: 10.1002/oby.22719Brix JM, Kopp HP, Höllerl F et al. Frequency of Hypoglycaemia after Different Bariatric Surgical Procedures. Obes Facts. 2019; 12(4):397-406. doi:10.1159/000493735 DOI: 10.1159/000493735Brix JM, Kopp HP, Höllerl F et al. Frequency of Hypoglycaemia after Different Bariatric Surgical Procedures. Obes Facts. 2019; 12(4):397-406. doi:10.1159/000493735 DOI: 10.1159/000493735Salehi M, Vella A, McLaughlin, et al. Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies. J Clin Endocrinol Metab. 2018; 103(8):2815-26. doi.org/10.1210/jc.2018-00528 DOI: 10.1210/jc.2018-00528Salehi M, Vella A, McLaughlin, et al. Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies. J Clin Endocrinol Metab. 2018; 103(8):2815-26. doi.org/10.1210/jc.2018-00528 DOI: 10.1210/jc.2018-00528Ким Е.И., Ершова Е.В., Мазурина Н.В., Комшилова К.А. Постбариатрические гипогликемии: взгляд эндокринолога. Ожирение и метаболизм. 2021; 18(4):471-483. DOI: 10.14341/omet12785Kim EI, Ershova EV, Mazurina NV, Komshilova KA. A view at postbariatric hypoglycemia by endocrinologist. Obesity and metabolism. 2022;18(4):471-483. (In Russ.)]. doi: https://doi.org/10.14341/omet12785«Алгоритмы специализированной медицинской помощи больным сахарным диабетом». Под редакцией И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 10-й выпуск (дополненный). Сахарный диабет. 2021; 24(1S):1-148. doi:https://doi.org/10.14341/DM12802Dedov II, Shestakova MV, Mayorov AYu, et al. Standards of specialized diabetes care. Diabetes Mellitus. 2021;24(S1):1-235 (In Russ.)]. doi: https://doi.org/10.14341/DM12802Tsur A, Machtinger R, Segal-Lieberman G, et al. Obesity, bariatric surgery and future fertility. Harefuah. 2014;153(8):478-81Tsur A, Machtinger R, Segal-Lieberman G, et al. Obesity, bariatric surgery and future fertility. Harefuah. 2014;153(8):478-81Guelinckx I, Devlieger R, Vansant G. Reproductive outcome after bariatric surgery: a critical review. Hum Reprod Update. 2009; 15(2):189-201 DOI: 10.1093/humupd/dmn057Guelinckx I, Devlieger R, Vansant G. Reproductive outcome after bariatric surgery: a critical review. Hum Reprod Update. 2009; 15(2):189-201 DOI: 10.1093/humupd/dmn057Kellogg TA, Bantle JP, Leslie DB, et al. Postgastric bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet. Surg Obes Relat Dis. 2008; 4(4):492-499. https://doi.org/10.1016/j.soard.2008.05.005 DOI: 10.1016/j.soard.2008.05.005Kellogg TA, Bantle JP, Leslie DB, et al. Postgastric bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet. Surg Obes Relat Dis. 2008; 4(4):492-499. https://doi.org/10.1016/j.soard.2008.05.005 DOI: 10.1016/j.soard.2008.05.005Botros N, Rijnaarts I, Brandts H, et al. Effect of carbohydrate restriction in patients with hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass. Obes Surg. 2014; 24(11):1850-1855. https://doi.org/10.1007/s11695-014-1319-6Botros N, Rijnaarts I, Brandts H, et al. Effect of carbohydrate restriction in patients with hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass. Obes Surg. 2014; 24(11):1850-1855. https://doi.org/10.1007/s11695-014-1319-6Goldfine AB, Mun EC, Devine E, et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab. 2007; 92(12):4678-4685. https://doi.org/10.1210/jc.2007-0918Goldfine AB, Mun EC, Devine E, et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab. 2007; 92(12):4678-4685. https://doi.org/10.1210/jc.2007-0918

The authors declare that there are no conflicts of interest present.